Order Article Reprints

Drefs M, Schirren MJ, Koch DT, Jacobi SJ, Neuberger M, Holdt LM, Renz BW, Werner J, Guba MO, Koliogiannis D. Tacrolimus (FK506) Attenuates Hepatic Ischemia–Reperfusion Injury via Oxidative Glutathione Metabolism and Suppression of Lipoxygenase-Mediated Cell Death. Antioxidants. 2026; 15(5):557. https://doi.org/10.3390/antiox15050557

Drefs, Moritz, Malte J. Schirren, Dominik T. Koch, Severin J. Jacobi, Michael Neuberger, Lesca M. Holdt, Bernhard W. Renz, Jens Werner, Markus O. Guba, and Dionysios Koliogiannis. 2026. "Tacrolimus (FK506) Attenuates Hepatic Ischemia–Reperfusion Injury via Oxidative Glutathione Metabolism and Suppression of Lipoxygenase-Mediated Cell Death" Antioxidants 15, no. 5: 557. https://doi.org/10.3390/antiox15050557

Drefs, M., Schirren, M. J., Koch, D. T., Jacobi, S. J., Neuberger, M., Holdt, L. M., Renz, B. W., Werner, J., Guba, M. O., & Koliogiannis, D. (2026). Tacrolimus (FK506) Attenuates Hepatic Ischemia–Reperfusion Injury via Oxidative Glutathione Metabolism and Suppression of Lipoxygenase-Mediated Cell Death. Antioxidants, 15(5), 557. https://doi.org/10.3390/antiox15050557